IPO - Mycotopia Therapies, Inc.

Form Type: 253G2

Filing Date: 2025-07-03

Corporate Action: Ipo

Type: New

Accession Number: 000109690625001087

Filing Summary: Aibotics, Inc., a Nevada corporation, is conducting a public offering of common stock under Rule 253(g)(2) for a maximum offering of $5,000,000. The offering price is set at $0.003 per share, with a minimum purchase requirement of $5,000. The offering will remain open for twelve months from the date of qualification, extendable by 30 days, or until the maximum amount is sold. There are no funds placed in escrow; proceeds will be available for company use upon acceptance of subscriptions. The company has changed its name from Mycotopia Therapies, Inc. to Aibotics, Inc. as of February 3, 2025. The common stock is intended for investors who are qualified purchasers, as defined in Regulation A, and sales will be made on a best-efforts basis by the company's officers. Aibotics ceased operations in the psychedelics business and has shifted focus towards AI and robotics solutions. The company has also structured employee incentive agreements linked to revenue generated from recently acquired assets. Significant risks are highlighted in the offering circular, including potential adverse implications for the company's financial condition and operational continuation due to losses. The common stock will be traded on the OTC Pink marketplace under the new symbol AIBT, following changes made with FINRA.